Pasar al contenido principal

IDENTIFICACION Y ESTUDIO FUNCIONAL DE NUEVOS DEFECTOS MOLECULARES EN DISPLASIAS ESQUELETICAS

SAF2017-84646-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIV. LA PAZ

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Interaction between KDELR2 and HSP47 as a Key Determinant in Osteogenesis Imperfecta Caused by Bi-allelic Variants in KDELR2

  • Van Dijk, Fleur S.
  • Semler, Oliver
  • Etich, Julia
  • Köhler, Anna
  • Jiménez-Estrada, Juan Andrés
  • Bravenboer, Nathalie
  • Claeys, Lauria
  • Riesebos, Elise
  • Gegic, Sejla
  • Piersma, Sander R.
  • Jimenez, Connie R.
  • Waisfisz, Quinten
  • Flores, Carmen-Lisset
  • Nevado, Julian
  • Harsevoort, Arjan J.
  • Janus, Guus J. M.
  • Franken, Anton A. M.
  • Van der Sar, Astrid M.
  • Meijers-Heijboer, Hanne
  • Heath, Karen E.
  • Lapunzina, Pablo
  • Nikkels, Peter G. J.
  • Santen, Gijs W. E.
  • Nüchel, Julian
  • Plomann, Markus
  • Wagener, Raimund
  • Rehberg, Mirko
  • Hoyer-Kuhn, Heike
  • Eekhoff, Elisabeth M. W.
  • Pals, Gerard
  • Mörgelin, Matthias
  • Newstead, Simon
  • Wilson, Brian T.
  • Ruiz-Pérez, Victor L.
  • Maugeri, Alessandra
  • Netzer, Christian
  • Zaucke, Frank
  • Micha, Dimitra
Osteogenesis imperfecta (OI) is characterized primarily by susceptibility to fractures with or without bone deformation. OI is genetically heterogeneous: over 20 genetic causes are recognized. We identified bi-allelic pathogenic KDELR2 variants as a cause of OI in four families. KDELR2 encodes KDEL endoplasmic reticulum protein retention receptor 2, which recycles ER-resident proteins with a KDEL-like peptide from the cis-Golgi to the ER through COPI retrograde transport. Analysis of patient primary fibroblasts showed intracellular decrease of HSP47 and FKBP65 along with reduced procollagen type I in culture media. Electron microscopy identified an abnormal quality of secreted collagen fibrils with increased amount of HSP47 bound to monomeric and multimeric collagen molecules. Mapping the identified KDELR2 variants onto the crystal structure of G. gallus KDELR2 indicated that these lead to an inactive receptor resulting in impaired KDELR2-mediated Golgi-ER transport. Therefore, in KDELR2-deficient individuals, OI most likely occurs because of the inability of HSP47 to bind KDELR2 and dissociate from collagen type I. Instead, HSP47 remains bound to collagen molecules extracellularly, disrupting fiber formation. This highlights the importance of intracellular recycling of ER-resident molecular chaperones for collagen type I and bone metabolism and a crucial role of HSP47 in the KDELR2-associated pathogenic mechanism leading to OI., Dimitra Micha is funded by the Amsterdam Movement Sciences Innovation call grant. The work of Dimitra Micha, Gerard Pals and Lauria Claeys is funded by the kind donation of Hans Horsting and Mary Horsting-Stuit of the Horstingstuit foundation. The Netherlands Organisation for Scientific Research (NWO‐Middelgroot project number 91116017) is acknowledged for support of the mass spectrometry infrastructure. The work of Julia Etich, Mirko Rehberg, Oliver Semler and Frank Zaucke was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) through RU2722 – 407168728 to OS and FZ and 407164210 to RW and by “Deutsche Gesellschaft für Osteogenesis imperfecta – Stiftung Baden-Württemberg” to OS. The Cologne Center for Genomics (CCG) is acknowledged for performing WES sequencing of P1. Christian Netzer would like to thank Florian Erger (Institute of Human Genetics, Cologne) for bioinformatics support with NGS data analysis. The work from Juan A Jimenez-Estrada, Julian Nevado, Karen E Heath, Pablo Lapunzina and Victor L Ruiz-Perez was supported by the Fundación AHUCE, CIBERER (ACCI 2017) and grants from the Spanish Ministry of Economy and Competitiveness (MINECO) to Victor L Ruiz-Perez (SAF2016‐ 75434‐R (AEI/FEDER, UE) and PID2019-105620RB-I00/AEI/10.13039/501100011033) and to Karen Heath (SAF2017-84646-R). They would also like to thank Dr. Pilar Gutierrez for clinical advice and Julia Piniella (Fundacion Ahuce) for coordination tasks during this project. We are grateful to the staff in the BioEM Lab, Biozentrum, University of Basel, and the Core Facility for Integrated Microscopy (CFIM), Panum Institute, University of Copenhagen, for providing highly innovative environments for electron microscopy. We thank Carola Alampi (BioEM lab), Mohamed Chami (BioEM lab) and Klaus Qvortrup (CFIM) for practical help with electron microscopy. We thank the technical expertise of Ferdy K Cayami at the Clinical Genetics department of the Amsterdam UMC whose work was funded by the High Reputation of International Publication Grant of Diponegoro University, Republic of Indonesia (No.329‐113/UN7.P4.3/PP/2019). Recruitment of affected individuals to this study was aided by the use of GeneMatcher.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mutations in TOP3A Cause a Bloom Syndrome-like Disorder

  • Martin, Carol-Anne
  • Sarlós, Kata
  • Logan, Clare V.
  • Singh Thakur, Roshan
  • Parry, David A.
  • Bizard, Anna H.
  • Leitch, Andrea
  • Cleal, Louise
  • Shaukat Ali, Nadia
  • Al-Owain, Mohammed A.
  • Allen, William
  • Altmüller, Janine|||0000-0003-4372-1521
  • Aza-Carmona, Miriam|||0000-0003-4448-9541
  • Barakat, Bushra A. Y.
  • Barraza-García, Jimena
  • Begtrup, Amber
  • Bogliolo, Massimo|||0000-0001-8240-7784
  • Cho, Megan T.
  • Cruz-Rojo, Jaime
  • Mundi Dhahrabi, Hassan Ali
  • Elcioglu, Nursel H.
  • Gorman, Gráinne S.|||0000-0002-7585-3409
  • Jobling, Rebekah
  • Kesterton, Ian
  • Kishita, Yoshihito
  • Kohda, Masakazu
  • Quesne Stabej, Polona Le
  • Jassim Malallah, Asam
  • Nürnberg, Peter
  • Ohtake, Akira
  • Okazaki, Yasushi
  • Pujol Calvet, Maria Roser|||0000-0003-1840-5455
  • Ramírez de Haro, Ma. José|||0000-0003-1417-7731
  • Revah-Politi, Anya
  • Shimura, Masaru
  • Stevens, Paul
  • Taylor, Robert W.|||0000-0002-7768-8873
  • Turner, Lesley
  • Williams, Hywel
  • Wilson, Carolyn
  • Yigit, Gökhan
  • Zahavich, Laura
  • Alkuraya, Fowzan S.|||0000-0003-4158-341X
  • Surralles, Jordi|||0000-0002-4041-7519
  • Iglesias, Alejandro
  • Murayama, Kei
  • Wollnik, Bernd|||0000-0003-2589-0364
  • Dattani, Mehul
  • Heath, Karen E.
  • Hickson, Ian D.
  • Jackson, Andrew P.
Bloom syndrome, caused by biallelic mutations in BLM, is characterized by prenatal-onset growth deficiency, short stature, an erythematous photosensitive malar rash, and increased cancer predisposition. Diagnostically, a hallmark feature is the presence of increased sister chromatid exchanges (SCEs) on cytogenetic testing. Here, we describe biallelic mutations in TOP3A in ten individuals with prenatalonset growth restriction and microcephaly. TOP3A encodes topoisomerase III alpha (TopIIIa), which binds to BLM as part of the BTRR complex, and promotes dissolution of double Holliday junctions arising during homologous recombination. We also identify a homozygous truncating variant in RMI1, which encodes another component of the BTRR complex, in two individuals with microcephalic dwarfism. The TOP3A mutations substantially reduce cellular levels of TopIIIa, and consequently subjects' cells demonstrate elevated rates of SCE. Unresolved DNA recombination and/or replication intermediates persist into mitosis, leading to chromosome segregation defects and genome instability that most likely explain the growth restriction seen in these subjects and in Bloom syndrome. Clinical features of mitochondrial dysfunction are evident in several individuals with biallelic TOP3A mutations, consistent with the recently reported additional function of TopIIIa in mitochondrial DNA decatenation. In summary, our findings establish TOP3A mutations as an additional cause of prenatal-onset short stature with increased cytogenetic SCEs and implicate the decatenation activity of the BTRR complex in their pathogenesis.